Literature DB >> 2807788

Local hypothermia protects the retina from ischemia. A quantitative study in the rat.

N Faberowski1, E Stefansson, R C Davidson.   

Abstract

We developed a quantitative histologic method for assessing injury in the rat retina due to transient ischemia. We used this technique to test the effectiveness of local hypothermia and allopurinol, an inhibitor of oxygen-free radical formation, in reducing ischemia/reperfusion injury in the rat retina. Retinal ischemia and reperfusion was produced by transient ligation of the optic nerve. Histologic evaluation by a masked observer was based on the average count of nonpyknotic nuclei in the inner nuclear layer of the retina from eight high power fields (X100) in one 5 microns thick sagital section at or near the optic nerve. A sharp increase in tissue damage occurs between 90 and 120 min of ischemia. Ischemia for periods of 60 and 90 min produced mild damage while periods of 120 and 240 min produced severe damage. Hypothermia protected the retina significantly from 120 min of ischemic injury (P less than 0.001 student t-test, compared to 120 min control), while allopurinol had no protective effect.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807788

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) in retinal ischemic preconditioning.

Authors:  John C Dreixler; Anthony Bratton; Eugenie Du; Afzhal R Shaikh; Brian Savoie; Michael Alexander; Marcus M Marcet; Steven Roth
Journal:  Exp Eye Res       Date:  2010-11-20       Impact factor: 3.467

Review 2.  Perioperative visual loss: what do we know, what can we do?

Authors:  S Roth
Journal:  Br J Anaesth       Date:  2009-12       Impact factor: 9.166

3.  Post-ischemic conditioning in the rat retina is dependent upon ischemia duration and is not additive with ischemic pre-conditioning.

Authors:  John C Dreixler; Afzhal R Shaikh; Michael Alexander; Brian Savoie; Steven Roth
Journal:  Exp Eye Res       Date:  2010-06-23       Impact factor: 3.467

4.  Protein kinase B (Akt) and mitogen-activated protein kinase p38α in retinal ischemic post-conditioning.

Authors:  John C Dreixler; Ajay Sampat; Afzhal R Shaikh; Michael Alexander; Marcus M Marcet; Steven Roth
Journal:  J Mol Neurosci       Date:  2011-05-15       Impact factor: 3.444

5.  Ocular oxygen consumption during vitreoperfusion in the cat.

Authors:  N P Blair
Journal:  Trans Am Ophthalmol Soc       Date:  2000

6.  Delayed post-ischemic conditioning significantly improves the outcome after retinal ischemia.

Authors:  John C Dreixler; Jacqueline N Poston; Afzhal R Shaikh; Michael Alexander; Kelsey Y Tupper; Marcus M Marcet; Myriam Bernaudin; Steven Roth
Journal:  Exp Eye Res       Date:  2011-04-09       Impact factor: 3.467

Review 7.  Traumatic optic neuropathy: a review of current studies.

Authors:  Bin Chen; Hengsen Zhang; Qing Zhai; Huaipeng Li; Chunxia Wang; Yong Wang
Journal:  Neurosurg Rev       Date:  2022-01-16       Impact factor: 3.042

8.  Vitreous humor thermodynamics during phacoemulsification.

Authors:  Guillermo Salcedo-Villanueva; Veronica Kon-Jara; Mariana Harasawa; Guadalupe Cervantes-Coste; Daniel Ochoa-Contreras; Virgilio Morales-Cantón; José Luis Guerrero-Naranjo; Hugo Quiroz-Mercado; Maurice B Landers
Journal:  Int Ophthalmol       Date:  2014-08-07       Impact factor: 2.031

9.  Protective effects of vitamin E forms (alpha-tocopherol, gamma-tocopherol and d-alpha-tocopherol polyethylene glycol 1000 succinate) on retinal edema during ischemia-reperfusion injury in the guinea pig retina.

Authors:  Orhan Aydemir; Serdal Celebi; Turgut Yilmaz; Hayrettin Yekeler; A Sahap Kükner
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

10.  Severity of middle cerebral artery occlusion determines retinal deficits in rats.

Authors:  Rachael S Allen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Exp Neurol       Date:  2014-02-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.